data13F

CLDX – Celldex Therapeutics Inc

Held by 1 of 60 tracked investors in their latest 13F filing · 0 counted on Most owned (narrow-view filings excluded)

Investors holding1
Combined shares15,096
Combined reported value$489K

CLDX chart by TradingView. Live prices are TradingView's; all other numbers on this page are from 13F filings.

Ownership

Investor% of their portfolioChangeSharesReported valuePeriod
Paul Tudor Jones narrow view 0.00 New15,096$489KQ3 2026

Activity: last 4 quarters

PeriodInvestorChangeShares afterEffect on their portfolio (pts)
Q3 2026Paul Tudor Jones narrow view New15,0960.00
Q2 2026Paul Tudor Jones narrow view Closed00.01
Q1 2026Paul Tudor Jones narrow view New35,3930.01
Q4 2025Paul Tudor Jones narrow view Closed00.01

Added: opened or increased

PeriodInvestorChangeShares afterEffect on their portfolio (pts)
Q3 2026Paul Tudor Jones narrow view New15,0960.00
Q1 2026Paul Tudor Jones narrow view New35,3930.01

Reduced: reduced or closed

PeriodInvestorChangeShares afterEffect on their portfolio (pts)
Q2 2026Paul Tudor Jones narrow view Closed00.01
Q4 2025Paul Tudor Jones narrow view Closed00.01

History

1 peakQ3 2026: 1 tracked investors
Q1 2023: 1 tracked investorsQ2 2023: 1 tracked investorsQ3 2023: 1 tracked investorsQ4 2023: 1 tracked investorsQ1 2024: 1 tracked investorsQ4 2024: 1 tracked investorsQ1 2025: 1 tracked investorsQ3 2025: 1 tracked investorsQ1 2026: 1 tracked investorsQ3 2026: 1 tracked investors
20232026
Tracked investors reporting this stock, by quarter

Shares held, last 8 quarters

InvestorQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
Paul Tudor Jones15.1K–35.4K–31.6K–35.1K32.5K

– = not held that quarter. n/a = no holdings report for that quarter (not filed yet, or reported under another manager).